Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Apr 10, 2021 4:47pm
184 Views
Post# 32973222

Why I started posting less in StockHouse

Why I started posting less in StockHouse

I decided to post less as b*tching at each other all the time is not investing. That is pure and simple BS. I also thought the guy might buy millions of shares if I stop posting. I did not want to be a distraction. 

 

I still believe in the company as they are making good progress. Yes, the stock price is on a downward trend but that is not based on the progress.

Anyone can the stock price is down because of manipulation.

 

If you do your due diligence and trust that company and see the company is making progress. Then short-term share price does not mean anything. If you don't trust the company or the management then you keep holding your shares does not make any sense. Choose one of the options and you will be fine. 

 

Here is the progress I am talking about: 

 

  1. Medivolve started offers Antibody covid testing then they added PCR nasal swab test and Antigen test. Then they started offering PCR saliva tests in New York. All these tests were for people who have insurance or can afford to pay with a credit card. 
  2. Now Collection sites started working with other partner labs to offer GOVT (HRSA) funded covid testing to uninsured and undocumented people.  https://www.hrsa.gov/coviduninsuredclaim This covers people who have no insurance and can't afford to pay with a credit card.
  3. Collection sites also just started offering immune score tests with another lab. If someone does not want to get a vaccine. These tests by assessing multiple antibody types against multiple SARS-CoV-2 antigens, AditxtScore™ for COVID-19 indicates whether you have been exposed to the virus and generated an immune response to neutralize it. AditxtScore™ cannot guarantee you will not become infected in the future; however, a positive immune response suggests you can resist infection if exposed to the COVID-19 virus again. This test is for the long term, not just Covid.  
  4. Now Medivolve brings in the most impotent part, they just announced to sell a home-based PCR test. Home-based tests to be sold in convenience stores and big-box retailers across the United States, expanding on its mission to bring convenient, fast and reliable COVID-19 testing to more homes, schools and businesses.
  5. They can also generate revenue from Nuturell spray, wipes and hand sanitizer.
  6. We all know, they are also working to get a vaccine contract. If the company is successful in getting a vaccine contract that will be added revenue. 

 

Look at Therma, from how many months they are playing home-based testing card and trading at over $100 million market cap. They haven't even done the clinical trials in Canada and no revenue. 

 

Medivolve already has access to sell FDA EUA approved home-based PCR tests. Medivolve generated $10.5 million in the 4th quarter and from the announced numbers. We know at least $17.5 million revenue for the 1st quarter and with newly added Govt funded tests, the 2nd quarter should be better than the 1st quarter. 

 

  • At starting, collection sites had only 2 options, your insurance pay for these tests or you pay with your credit card. 
  • Now they added an option for the people with low income and who have no insurance. They can get tested with GOVT-funded money. 
  • Then they added another option for the people who want to see if a vaccine is still working on them. 
  • Another option collection sites just added is home-based PCR tests. These PCR tests are required for travel

 

Collection sites also started working with more labs to offer timely results. So far I see they are working with 4 different labs now. All these labs have many different tests and those tests can be offered after covid as part of telehealth and diagnostic.

 

I think Doug Sommerville is making good progress bringing in all these new revenue streams. If anything can be changed, that is to let go Stan Bharti appointed directors. Then add new people with experience in medical service to help Doug managing day to day operations. 

 

I also think they dropped the ball on advertising collection sites. 

 

Once Medivolve starts selling Nuturell products and signing the sales contract. Sign and announce vaccine contract. Start announcing big-box stores agreement to sell home-based tests. A new website selling home-based testing and Nuturell products. A successful Blowfish clinical trial result. All or some of these are achieved in the next 3-6 weeks. We will see stock price moving in the right direction. 

<< Previous
Bullboard Posts
Next >>